Variant report
Variant | nsv979762 |
---|---|
Chromosome Location | chr3:22085839-22088433 |
allele | n/a |
Outlinks | Ensembl   UCSC |
- TF binding region (count:0)
- CpG islands (count:0)
- Chromatin interactive region (count:0)
- LncRNA region (count:0)
- Mature miRNA region (count: 0)
- miRNA target sites (count:0)
No data |
No data |
No data |
No data |
No data |
No data |
No data |

No. | Variant name | Chromosome position | Chromatin state | Related regulatory elements | Target genes | Extended variants | Associated traits |
---|---|---|---|---|---|---|---|
1 | rs148515572 | chr3:22087409-22087410 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
2 | rs75112654 | chr3:22087414-22087415 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
3 | rs565519792 | chr3:22087420-22087421 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
4 | rs543533443 | chr3:22087444-22087445 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
5 | rs187738281 | chr3:22087449-22087450 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
6 | rs536267224 | chr3:22087462-22087463 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
7 | rs259462 | chr3:22087474-22087475 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
8 | rs7632328 | chr3:22087497-22087498 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
9 | rs373178299 | chr3:22087513-22087514 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
10 | rs34362610 | chr3:22087533-22087534 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
11 | rs569778155 | chr3:22087542-22087543 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
12 | rs377025448 | chr3:22087555-22087556 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
13 | rs374422662 | chr3:22087572-22087573 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
14 | rs79280614 | chr3:22087575-22087576 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
15 | rs375102330 | chr3:22087576-22087577 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
16 | rs11421787 | chr3:22087582-22087583 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
17 | rs397691376 | chr3:22087584-22087585 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
18 | rs577143061 | chr3:22087606-22087607 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
19 | rs540945933 | chr3:22087660-22087661 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
20 | rs190872518 | chr3:22087687-22087688 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
21 | rs572313665 | chr3:22087691-22087692 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
22 | rs13071653 | chr3:22087693-22087694 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
23 | rs77691317 | chr3:22087697-22087698 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
24 | rs140080076 | chr3:22087734-22087735 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
25 | rs531690928 | chr3:22087760-22087761 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
26 | rs138594634 | chr3:22087788-22087789 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
27 | rs547694133 | chr3:22087819-22087820 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
28 | rs142863760 | chr3:22087854-22087855 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
29 | rs6774955 | chr3:22087876-22087877 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
30 | rs566001058 | chr3:22087879-22087880 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
31 | rs532772553 | chr3:22087906-22087907 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
32 | rs6790190 | chr3:22087938-22087939 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
33 | rs549892408 | chr3:22087971-22087972 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
34 | rs569817134 | chr3:22088011-22088012 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
35 | rs151054054 | chr3:22088049-22088050 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
36 | rs141002474 | chr3:22088064-22088065 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
37 | rs532457274 | chr3:22088079-22088080 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
38 | rs61678164 | chr3:22088086-22088087 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
39 | rs569706937 | chr3:22088093-22088094 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
40 | rs186903534 | chr3:22088109-22088110 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
41 | rs558713937 | chr3:22088132-22088133 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
42 | rs570525949 | chr3:22088140-22088141 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
43 | rs370733374 | chr3:22088153-22088154 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
44 | rs552948142 | chr3:22088179-22088180 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
45 | rs375761410 | chr3:22088180-22088181 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
46 | rs259463 | chr3:22088181-22088182 | Enhancers | n/a | n/a | LD-proxies of rSNPOverlapped rCNV | n/a |
47 | rs192162621 | chr3:22088200-22088201 | Enhancers | n/a | n/a | Overlapped CNVs | n/a |
Disease | PMID | Source |
---|---|---|
Medulloblastoma | 21979893 | CNVD |
Esophageal squamous carcinoma | 18405350 | CNVD |
Chronic lymphocytic leukemia | 21546498 | CNVD |
Breast cancer | 17603634 | CNVD |
Neuroblastoma | 17327916 | CNVD |
Glioblastoma multiforme | 21080181 | CNVD |
Neuroblastoma | 18923191 | CNVD |
Colorectal cancer | 21297112 | CNVD |
Lynch syndrome | 18415027 | CNVD |
Renal cell carcinoma | 18592004 | CNVD |
Acute myeloid leukemia | 20729466 | CNVD |
Urothelial carcinoma | 18382360 | CNVD |
Melanoma | 18172304 | CNVD |
Cervical cancer | 21062161 | CNVD |
Hirschsprung''s Disease | 21712996 | CNVD |
head and neck squamous cell carcinoma | 17671120 | CNVD |
Insulin resistance | 16721378 | CNVD |
Neuroblastoma | 18664255 | CNVD |
Monoclonal gammopathy of undetermined significance | 17077331 | CNVD |
Multiple myeloma | 17077331 | CNVD |
Oral squamous cell carcinoma | 17134496 | CNVD |
Ewing''s sarcoma | 21437220 | CNVD |
Neuroblastoma | 21484798 | CNVD |
Non-small cell lung cancer | 21044232 | CNVD |
Non-syndromic sensorineural hearing loss | 18471307 | CNVD |
Oral cancer | 19627613 | CNVD |
Renal cell carcinoma | 19461508 | CNVD |
Epithelial cancer | 22065749 | CNVD |
Acute lymphoblastic leukemia | 21390130 | CNVD |
Acute myeloid leukemia | 16864856 | CNVD |
Liposarcoma | 21253554 | CNVD |
Basal cell lymphoma | 21115979 | CNVD |
Endometrial cancer | 22040021 | CNVD |
Pancreatic endocrine tumor | 20981439 | CNVD |
Astrocytoma | 17387387 | CNVD |
Breast cancer | 21264507 | CNVD |
Esophageal squamous carcinoma | 21637470 | CNVD |
Glioblastoma multiforme | 17387387 | CNVD |
Oral cancer | 21386901 | CNVD |
Cutaneous squamous cell carcinomas | 19131950 | CNVD |
Basal cell lymphoma | 17053054 | CNVD |
Esophageal cancer | 21851588 | CNVD |
Uveal melanoma | 21693616 | CNVD |
Retinoblastoma | 21504564 | CNVD |
T-cell prolymphocytic leukemia | 17713554 | CNVD |
lymphocytic leukemia | 21291569 | CNVD |
T-cell prolymphocytic leukemia | 19278963 | CNVD |
Renal cell carcinoma | 21668985 | CNVD |
Acute lymphoblastic leukemia | 20435627 | CNVD |
Thoracic aortic aneurysm | 21092924 | CNVD |
Lung cancer | 20668451 | CNVD |
Breast cancer | 20668451 | CNVD |
Cancer | 20668451 | CNVD |
Ovarian cancer | 20668451 | CNVD |
Pancreas cancer | 20668451 | CNVD |
Prostate cancer | 20668451 | CNVD |
small cell lung cancer | 20016488 | CNVD |
Lung cancer | 18438408 | CNVD |
Intellectual disability | 22102821 | CNVD |
Esophageal cancer | 20955586 | CNVD |
Myeloproliferative neoplasm | 20015882 | CNVD |
Endometrioid adenocarcinoma | 16974079 | CNVD |
Myofibroblastic sarcoma | 19369631 | CNVD |
Myelofibrosis | 22110671 | CNVD |
Gastric adenocarcinoma | 19115996 | CNVD |
Squamous cell cancer | 20885788 | CNVD |
Esophageal squamous carcinoma | 17470683 | CNVD |
Breast cancer | 17133270 | CNVD |
Uveal melanoma | 20484589 | CNVD |
Autism | 22495311 | CNVD |
Cancer | 20164919 | CNVD |
Melanoma | 20688739 | CNVD |
Non-syndromic sensorineural hearing loss | 17122850 | CNVD |
Non-syndromic sensorineural hearing loss | 18451855 | CNVD |
No. | Chromosome Location | Chromatin state | Cell line | Tissue |
---|---|---|---|---|
1 | chr3:22087400-22087800 | Enhancers | H1 Cell Line | embryonic stem cell |
2 | chr3:22087400-22087800 | Enhancers | HUES48 Cell Line | embryonic stem cell |
3 | chr3:22087400-22088200 | Enhancers | iPS-18 Cell Line | embryonic stem cell |
4 | chr3:22088000-22088200 | Enhancers | Pancreatic Islets | Pancreatic Islet |